Aura Biosciences (AURA) Competitors $5.71 -0.23 (-3.87%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$6.03 +0.32 (+5.60%) As of 04/3/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AURA vs. INDV, AMPH, ETNB, ADPT, EVO, SPRY, ARDX, OCUL, GPCR, and CALTShould you be buying Aura Biosciences stock or one of its competitors? The main competitors of Aura Biosciences include Indivior (INDV), Amphastar Pharmaceuticals (AMPH), 89bio (ETNB), Adaptive Biotechnologies (ADPT), Evotec (EVO), ARS Pharmaceuticals (SPRY), Ardelyx (ARDX), Ocular Therapeutix (OCUL), Structure Therapeutics (GPCR), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. Aura Biosciences vs. Indivior Amphastar Pharmaceuticals 89bio Adaptive Biotechnologies Evotec ARS Pharmaceuticals Ardelyx Ocular Therapeutix Structure Therapeutics Calliditas Therapeutics AB (publ) Aura Biosciences (NASDAQ:AURA) and Indivior (NASDAQ:INDV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, community ranking, institutional ownership and earnings. Which has better earnings and valuation, AURA or INDV? Indivior has higher revenue and earnings than Aura Biosciences. Indivior is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAura BiosciencesN/AN/A-$76.41M-$1.75-3.26Indivior$1.19B1.09$2M-$0.35-26.80 Which has more volatility & risk, AURA or INDV? Aura Biosciences has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, Indivior has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Does the media prefer AURA or INDV? In the previous week, Aura Biosciences had 3 more articles in the media than Indivior. MarketBeat recorded 7 mentions for Aura Biosciences and 4 mentions for Indivior. Indivior's average media sentiment score of 1.45 beat Aura Biosciences' score of 0.78 indicating that Indivior is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aura Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Indivior 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate AURA or INDV? Aura Biosciences presently has a consensus target price of $23.00, indicating a potential upside of 302.80%. Indivior has a consensus target price of $15.00, indicating a potential upside of 59.91%. Given Aura Biosciences' higher possible upside, equities research analysts clearly believe Aura Biosciences is more favorable than Indivior.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aura Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Indivior 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Is AURA or INDV more profitable? Aura Biosciences has a net margin of 0.00% compared to Indivior's net margin of -3.96%. Aura Biosciences' return on equity of -41.57% beat Indivior's return on equity.Company Net Margins Return on Equity Return on Assets Aura BiosciencesN/A -41.57% -36.43% Indivior -3.96%-241.73%15.09% Does the MarketBeat Community prefer AURA or INDV? Aura Biosciences received 15 more outperform votes than Indivior when rated by MarketBeat users. However, 100.00% of users gave Indivior an outperform vote while only 65.00% of users gave Aura Biosciences an outperform vote. CompanyUnderperformOutperformAura BiosciencesOutperform Votes2665.00% Underperform Votes1435.00% IndiviorOutperform Votes11100.00% Underperform VotesNo Votes Do insiders and institutionals hold more shares of AURA or INDV? 96.8% of Aura Biosciences shares are owned by institutional investors. Comparatively, 60.3% of Indivior shares are owned by institutional investors. 5.4% of Aura Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryAura Biosciences beats Indivior on 10 of the 17 factors compared between the two stocks. Remove Ads Get Aura Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AURA vs. The Competition Export to ExcelMetricAura BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$286.79M$2.97B$5.54B$7.49BDividend YieldN/A1.53%4.86%4.04%P/E Ratio-3.3030.4323.2518.07Price / SalesN/A383.26361.2686.83Price / CashN/A168.6838.1634.64Price / Book1.253.646.493.99Net Income-$76.41M-$72.06M$3.21B$247.18M7 Day Performance-3.87%-10.59%-6.42%-6.42%1 Month Performance-20.80%-16.74%-0.68%-7.44%1 Year Performance-21.78%-30.77%6.05%-4.31% Aura Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AURAAura Biosciences2.2967 of 5 stars$5.71-3.9%$23.00+302.8%-21.8%$286.79MN/A-3.3050Gap DownHigh Trading VolumeINDVIndivior3.3897 of 5 stars$10.10+2.9%$15.00+48.5%-57.4%$1.39B$1.19B-28.861,164Positive NewsAMPHAmphastar Pharmaceuticals4.2227 of 5 stars$28.46+0.6%$43.50+52.8%-35.1%$1.36B$731.97M9.491,620News CoverageETNB89bio2.935 of 5 stars$9.15+7.4%$27.56+201.2%-36.9%$1.34BN/A-3.1440ADPTAdaptive Biotechnologies3.9182 of 5 stars$8.66+3.1%$9.40+8.5%+176.5%$1.29B$178.96M-7.94790Gap DownEVOEvotec1.5736 of 5 stars$3.63+3.4%$5.93+63.5%-57.9%$1.29B$777.05M0.004,200SPRYARS Pharmaceuticals3.075 of 5 stars$12.89+4.3%$31.00+140.5%+42.6%$1.25B$89.15M-25.2790High Trading VolumeARDXArdelyx4.186 of 5 stars$5.25+2.3%$10.95+108.6%-35.5%$1.25B$333.62M-32.8190Gap DownOCULOcular Therapeutix3.4607 of 5 stars$7.62+1.5%$16.38+114.9%-17.2%$1.21B$63.72M-5.77230GPCRStructure Therapeutics2.095 of 5 stars$21.05+0.4%$81.29+286.2%-59.2%$1.21BN/A-28.45136News CoverageGap DownCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180 Remove Ads Related Companies and Tools Related Companies Indivior Competitors Amphastar Pharmaceuticals Competitors 89bio Competitors Adaptive Biotechnologies Competitors Evotec Competitors ARS Pharmaceuticals Competitors Ardelyx Competitors Ocular Therapeutix Competitors Structure Therapeutics Competitors Calliditas Therapeutics AB (publ) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AURA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aura Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aura Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AURA Stock Free AURA Stock Alerts